AAAAAA

   
Results: 1-21 |
Results: 21
Thrombomodulin promoter mutations, venous thrombosis, and varicose veins
Authors: Le Flem, L Mennen, L Aubry, ML Aiach, M Scarabin, PY Emmerich, J Alhenc-Gelas, M
Citation: L. Le Flem et al., Thrombomodulin promoter mutations, venous thrombosis, and varicose veins, ART THROM V, 21(3), 2001, pp. 445-451
The effects of transdermal and oral estrogen/progesterone regimens on freeand total protein S in postmenopausal women
Authors: Marque, V Alhenc-Gelas, M Plu-Bureau, G Oger, E Scarabin, PY
Citation: V. Marque et al., The effects of transdermal and oral estrogen/progesterone regimens on freeand total protein S in postmenopausal women, THROMB HAEM, 86(2), 2001, pp. 713-714
Protein C concentrates in a neonate with a cerebral venous thrombosis due to heterozygous type 1 protein C deficiency
Authors: Tardy-Poncet, B Rayet, I Damon, G Alhenc-Gelas, M Dutour, N Lavocat, MP
Citation: B. Tardy-poncet et al., Protein C concentrates in a neonate with a cerebral venous thrombosis due to heterozygous type 1 protein C deficiency, THROMB HAEM, 85(6), 2001, pp. 1118-1119
Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy - Time-dependent change in transdermal,but not oral estrogen users
Authors: Oger, E Alhenc-Gelas, M Plu-Bureau, G Mennen, L Cambillau, M Guize, L Pujol, Y Scarabin, PY
Citation: E. Oger et al., Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy - Time-dependent change in transdermal,but not oral estrogen users, THROMB RES, 101(2), 2001, pp. 35-43
Intracerebral hemorrhage associated with a novel antithrombin gene mutation in a neonate
Authors: Baud, O Picard, V Durand, P Duchemin, J Proulle, V Alhenc-Gelas, M Devictor, D Dreyfus, M
Citation: O. Baud et al., Intracerebral hemorrhage associated with a novel antithrombin gene mutation in a neonate, J PEDIAT, 139(5), 2001, pp. 741-743
Factors v Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis
Authors: Meyer, G Emmerich, J Helley, D Arnaud, E Nicaud, V Alhenc-Gelas, M Aiach, M Fischer, AM Sors, H Fiessinger, JN
Citation: G. Meyer et al., Factors v Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis, AM J MED, 110(1), 2001, pp. 12-15
Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism
Authors: Arnaud, E Nicaud, V Poirier, O Rendu, F Alhenc-Gelas, M Fiessinger, JN Emmerich, J Aiach, M
Citation: E. Arnaud et al., Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism, ART THROM V, 20(2), 2000, pp. 585-592
The FXIII Val 34 Leu mutation and the risk of venous thrombosis
Authors: Alhenc-Gelas, M Reny, JL Aubry, ML Aiach, M Emmerich, J
Citation: M. Alhenc-gelas et al., The FXIII Val 34 Leu mutation and the risk of venous thrombosis, THROMB HAEM, 84(6), 2000, pp. 1117-1118
Plasma 17 beta estradiol is inversely correlated with circulating vascularcell adhesion molecule
Authors: Oger, E Alhenc-Gelas, M Plu-Bureau, G Guize, L Scarabin, PY
Citation: E. Oger et al., Plasma 17 beta estradiol is inversely correlated with circulating vascularcell adhesion molecule, THROMB HAEM, 84(6), 2000, pp. 1125-1125
Demonstration of an association between Chlamydia pneumoniae infection andvenous thromboembolic disease
Authors: Lozinguez, O Arnaud, E Belec, L Nicaud, V Alhenc-Gelas, M Fiessinger, JN Aiach, M Emmerich, J
Citation: O. Lozinguez et al., Demonstration of an association between Chlamydia pneumoniae infection andvenous thromboembolic disease, THROMB HAEM, 83(6), 2000, pp. 887-891
Thirty-three novel mutations in the protein C gene
Authors: Alhenc-Gelas, M Gandrille, S Aubry, ML Aiach, M
Citation: M. Alhenc-gelas et al., Thirty-three novel mutations in the protein C gene, THROMB HAEM, 83(1), 2000, pp. 86-92
Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene
Authors: Picard, V Bura, A Emmerich, J Alhenc-Gelas, M Biron, C Houbouyan-Reveillard, LL Molho, P Labatide-Alanore, A Sie, P Toulon, P Verdy, E Aiach, M
Citation: V. Picard et al., Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene, BR J HAEM, 110(3), 2000, pp. 731-734
Hypercoagulable states in primary upper-extremity deep vein thrombosis
Authors: Heron, E Lozinguez, O Alhenc-Gelas, M Emmerich, J Fiessinger, JN
Citation: E. Heron et al., Hypercoagulable states in primary upper-extremity deep vein thrombosis, ARCH IN MED, 160(3), 2000, pp. 382-386
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk
Authors: Aiach, M Nicaud, V Alhenc-Gelas, M Gandrille, S Arnaud, E Amiral, J Guize, L Fiessinger, JN Emmerich, J
Citation: M. Aiach et al., Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk, ART THROM V, 19(6), 1999, pp. 1573-1576
Mutations in promoter region of thrombomodulin and venous thromboembolic disease
Authors: Le Flem, L Picard, V Emmerich, J Gandrille, S Fiessinger, JN Aiach, M Alhenc-Gelas, M
Citation: L. Le Flem et al., Mutations in promoter region of thrombomodulin and venous thromboembolic disease, ART THROM V, 19(4), 1999, pp. 1098-1104
Hormone replacement therapy and circulating ICAM-1 in postmenopausal women- A randomised controlled trial
Authors: Scarabin, PY Alhenc-Gelas, M Oger, E Plu-Bureau, G
Citation: Py. Scarabin et al., Hormone replacement therapy and circulating ICAM-1 in postmenopausal women- A randomised controlled trial, THROMB HAEM, 81(5), 1999, pp. 673-675
Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes
Authors: Alhenc-Gelas, M Arnaud, E Nicaud, V Aubry, ML Fiessinger, JN Aiach, M Emmerich, J
Citation: M. Alhenc-gelas et al., Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes, THROMB HAEM, 81(4), 1999, pp. 506-510
The factor V gene A4070G mutation and the risk of venous thrombosis
Authors: Alhenc-Gelas, M Nicaud, V Gandrille, S van Dreden, P Amiral, J Aubry, ML Fiessinger, JN Emmerich, J Aiach, M
Citation: M. Alhenc-gelas et al., The factor V gene A4070G mutation and the risk of venous thrombosis, THROMB HAEM, 81(2), 1999, pp. 193-197
Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor VArg 506 to Gln mutation
Authors: Le Cam-Duchez, V Gandrille, S Tregouet, D Alhenc-Gelas, M Emmerich, J Fiessinger, JN Borg, JY Aiach, M
Citation: V. Le Cam-duchez et al., Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor VArg 506 to Gln mutation, BR J HAEM, 106(4), 1999, pp. 889-897
Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: Two cases in a French family
Authors: Zawadzki, C Gaveriaux, V Trillot, N Bauters, A Watel, A Alhenc-Gelas, M Preudhomme, C Jude, B
Citation: C. Zawadzki et al., Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: Two cases in a French family, THROMB HAEM, 80(6), 1998, pp. 1027-1028
Venous thrombosis in older people: Prevalence of the factor V gene mutation Q506
Authors: Andre, E Siguret, V Alhenc-Gelas, M Saint-Jean, O Gaussem, P
Citation: E. Andre et al., Venous thrombosis in older people: Prevalence of the factor V gene mutation Q506, J AM GER SO, 46(12), 1998, pp. 1545-1549
Risultati: 1-21 |